@Groupe PSA: OP In lockstep to win the day000865

Newly promoted Hamburger SV defied series champions Bayern Munich to take a point, and Mainz, who were threatened with relegation, won away from Champions League aspirants Leipzig. These were the big surprises of this 20th Bundesliga matchday. The two daily winners of our betting game didn’t have these results on their list either. Otherwise, “Heiwa”… Continue reading @Groupe PSA: OP In lockstep to win the day000865

German FAZ: Kaja now weighs 277 kilos010511

It wasn’t just Kaja’s fault that more visitors came to the Opel Zoo in Taunus last year than ever before. But the birth of the first elephant calf in Hesse in 57 years contributed to the record. The Kronberg Zoo counted exactly 648,090 visitors at the end of the year, as zoo director Thomas Kauffels… Continue reading German FAZ: Kaja now weighs 277 kilos010511

German FAZ: Police: So far no evidence of illegal car racing010511

After the serious collision on Autobahn 3 near Frankfurt, police investigations are focusing on a 22-year-old man who is suspected of having caused the accident. According to his own statements, he was driving the car, which, according to witnesses, overtook several vehicles on the left and right at high speed before colliding with another vehicle… Continue reading German FAZ: Police: So far no evidence of illegal car racing010511

FARE Releases New Public Service Announcement in Ready to Act Campaign Featuring Actor, Food Allergy Parent and FARE Ambassador Tia Mowry

McLEAN, Va. , Feb. 2, 2026 /PRNewswire/ — FARE (Food Allergy Research & Education), the leading charity that supports those impacted by food allergy through advocacy, research and education, today announced the release of a new public service announcement (PSA) featuring actor, food allergy parent and FARE Ambassador Tia Mowry. The PSA, part of the organization’s Ready to Act campaign, is titled… Continue reading FARE Releases New Public Service Announcement in Ready to Act Campaign Featuring Actor, Food Allergy Parent and FARE Ambassador Tia Mowry

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

The new technology is the world’s smallest, catheter-delivered defibrillation lead AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or… Continue reading Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

Texas Cardiac Arrhythmia Institute am St. David’s Medical Center implantiert als erstes in den USA die von der FDA zugelassene neuartige Defibrillationselektrode

Die neue Technologie ist die weltweit kleinste, über einen Katheter zugeführte Defibrillationselektrode AUSTIN, Texas, 2. Februar 2026 /PRNewswire/ — Elektrophysiologen am Texas Cardiac Arrhythmia Institute (TCAI) am St. David’s Medical Center haben kürzlich als erste in den USA eine von der FDA zugelassene neuartige Defibrillationsleitung implantiert – ein spezieller, isolierter Draht, der mit einem implantierbaren… Continue reading Texas Cardiac Arrhythmia Institute am St. David’s Medical Center implantiert als erstes in den USA die von der FDA zugelassene neuartige Defibrillationselektrode

Le Texas Cardiac Arrhythmia Institute du St. David’s Medical Center est le premier aux États-Unis à implanter une nouvelle sonde de défibrillation approuvée par la FDA

Cette nouvelle technologie est la plus petite sonde de défibrillation délivrée par cathéter au monde AUSTIN, Texas, 2 février 2026 /PRNewswire/ — Les électrophysiologistes du Texas Cardiac Arrhythmia Institute (TCAI) du St. David’s Medical Center ont récemment été les premiers au pays à implanter une nouvelle sonde de défibrillation approuvée par la FDA – un… Continue reading Le Texas Cardiac Arrhythmia Institute du St. David’s Medical Center est le premier aux États-Unis à implanter une nouvelle sonde de défibrillation approuvée par la FDA